ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DDDD 4d Pharma Plc

16.36
0.00 (0.00%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
4d Pharma Plc LSE:DDDD London Ordinary Share GB00BJL5BR07 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 16.36 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

4d Pharma PLC Holding(s) in Company (4509J)

09/09/2016 11:58am

UK Regulatory


TIDMDDDD TIDMAV.

RNS Number : 4509J

4d Pharma PLC

09 September 2016

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
----------------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                     4D Pharma plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
---------------------------------------------------------------  ------------------------------------ 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
----------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
---------------------------------------------------------------------  ------------------------------ 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
---------------------------------------------------------------------  ------------------------------ 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
---------------------------------------------------------------------  ------------------------------ 
 An event changing the breakdown of voting rights 
---------------------------------------------------------------------  ------------------------------ 
 Other (please 
  specify): 
-----------------------------------------------------------  --------  ------------------------------ 
 3. Full name of person(s)                                      Aviva plc & its subsidiaries 
  subject to the 
  notification obligation: 
  (iii) 
-------------------------------------------------------------  -------------------------------------- 
 4. Full name of shareholder(s)                                 Registered Holder: 
  (if different from 3.):(iv) 
                                                                 BNY Norwich Union 
                                                                 Nominees Limited 143,637* 
 
                                                                 Chase (GA Group) 
                                                                 Nominees Limited 2,096,957* 
                                                                 * denotes direct interest 
                                                                 Chase (GA Group) 
                                                                 Nominees Limited 175,084 
                                                                 Chase Nominees 
                                                                 Limited 83,372 
                                                                 Vidacos Nominees 
                                                                 Limited 118,418 
-------------------------------------------------------------  -------------------------------------- 
 5. Date of the transaction                                     06 July 2016 
  and date on 
  which the threshold is crossed 
  or 
  reached: (v) 
-------------------------------------------------------------  -------------------------------------- 
 6. Date on which issuer notified:                              07 July 2016 
-------------------------------------------------------------  -------------------------------------- 
 7. Threshold(s) that is/are                                    5% to <5% Change at Combined 
  crossed or                                                    Interest Level (Box 8A & 8B) 
  reached: (vi, vii) 
-------------------------------------------------------------  -------------------------------------- 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------- 
 Class/type          Situation previous               Resulting situation after the 
  of                  to the triggering                triggering transaction 
  shares              transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
------------------  -------------------------------  --------------------------------------------------------- 
                     Number              Number       Number        Number of               % of voting 
                      of                  of           of            voting                  rights (x) 
                      Shares              Voting       shares        rights 
                                          Rights 
------------------  ------------------  -----------  ------------  ----------------------  ------------------- 
                                                      Direct        Direct      Indirect    Direct   Indirect 
                                                                     (xi)        (xii) 
------------------  ------------------  -----------  ------------  ----------  ----------  -------  ---------- 
 
  Ordinary 
  Shares 
 
  GB00BJL5BR07 
                                                     ------------              ----------           ---------- 
                        3,276,932*       3,276,932*   2,617,468     2,240,594    376,874    3.46%      0.58% 
------------------  ------------------  -----------  ------------  ----------  ----------  -------  ---------- 
 
   * Includes Right to Recall Loaned Shares (350,800) 
-------------------------------------------------------------------------------------------------------------- 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------- 
 Type of financial   Expiration          Exercise/                  Number of voting        % of voting 
  instrument          date                Conversion                 rights that             rights 
                      (xiii)              Period (xiv)               may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
------------------  ------------------  -------------------------  ----------------------  ------------------- 
 
 
                                                                      617,754* 
 RIGHT TO RECALL 
  LOANED SHARES      N/A                 N/A                          * Direct Interest     0.95% 
------------------  ------------------  -------------------------  ----------------------  ------------------- 
 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting 
  instrument          price      date         Conversion    rights instrument    rights (xix, 
                                 (xvii)       period        refers to            xx) 
                                              (xviii) 
------------------  ---------  -----------  ------------  -------------------  ---------------- 
                                                                                Nominal   Delta 
------------------  ---------  -----------  ------------  -------------------  --------  ------ 
 
 
 
 Total (A+B+C) 
------------------------------------------------------ 
 Number of voting rights   Percentage of voting rights 
------------------------  ---------------------------- 
 3,235,222                 4.99% 
------------------------  ---------------------------- 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
--------------------------------------------------------------- 
 The voting rights are managed and controlled by Aviva 
  Investors Global Services Limited, with the following 
  chain of controlled undertakings:- 
 
  Aviva Investors Global Services Limited: 
   *    Aviva plc (Parent Company) 
 
 
   *    Aviva Group Holdings Limited (wholly owned subsidiary 
        of Aviva plc) 
 
 
   *    Aviva Investors Holdings Limited (wholly owned 
        subsidiary of Aviva Group Holdings Limited) 
 
 
   *    Aviva Investors Global Services Limited (wholly owned 
        subsidiary of Aviva Investors Holdings Limited) 
 
 Proxy Voting: 
--------------------------------------------------------------- 
 10. Name of the proxy holder:                 See Section 4 
--------------------------------------------  ----------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
--------------------------------------------  ----------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
--------------------------------------------  ----------------- 
 
 
 
  13. Additional information:      Figures are based on the total 
                                   number of voting rights of 
                                   64,858,150 as per the Company's 
                                   'Acquisition' announcement 
                                   of 8 April 2016. 
-------------------------------  --------------------------------- 
 14. Contact name:                    Neil Whittaker, Aviva plc 
-------------------------------  --------------------------------- 
 15. Contact telephone number:        01603 684420 
-------------------------------  --------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLLLFEIAVIAIIR

(END) Dow Jones Newswires

September 09, 2016 06:58 ET (10:58 GMT)

1 Year 4d Pharma Chart

1 Year 4d Pharma Chart

1 Month 4d Pharma Chart

1 Month 4d Pharma Chart

Your Recent History

Delayed Upgrade Clock